Praxis Medica
Sign in
Issue image

More articles from Volume 33, Issue 1, 2005

CHARACTERISTIC OF MYOCARDIAL INFARCTION IN DIABETIC PATIENTS

THE ROLE OF ANTROPOLOGISTS IN FORENSIC INVESTIGATIONS EXHUMED DEAD BODIES IN KOSOVO AND METOHIA FROM 2001. to 2004.

VITREOUS HAEMORRHAGIAE IN PENETRATING EYE INJURES IN CHILDREN

LUTEAL PHASE DEFECT IN WOMEN WITH HYPERPROLACTINEMIA AND UNKNOWN REASON OF INFERTILITY

SIGNIFICANCE OF THE FISTULOGRAPHY FOR OPERATIVE TREATMENT OF THE FISTULA-IN-ANO

DYNAMIC OF LEFT VENTRICULAR VOLUME AFTER ACUTE MYOCARDIAL INFARCTION UNDER THERAPY WITH ACE INHIBITORS

I. Ivanov ,
I. Ivanov

Institute of cardiovascular disease , Sremska Kamenica , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
J. Dejanović ,
J. Dejanović

Institute of cardiovascular disease , Sremska Kamenica , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
I. Čurić ,
I. Čurić

Institute of cardiovascular disease , Sremska Kamenica , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
J. Čikoš ,
J. Čikoš

Institute of cardiovascular disease , Sremska Kamenica , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
M. Vindiš-Ješić ,
M. Vindiš-Ješić

Institute of cardiovascular disease , Sremska Kamenica , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
D. Živkov-Šaponja ,
D. Živkov-Šaponja

Institute of cardiovascular disease , Sremska Kamenica , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
D. Hostić ,
D. Hostić

Institute of cardiovascular disease , Sremska Kamenica , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
M. Mišolić
M. Mišolić

Institute of cardiovascular disease , Sremska Kamenica , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar

Published: 01.01.2005.

Volume 33, Issue 1 (2005)

pp. 39-42;

https://doi.org/10.70949/pramed200501110I

Abstract

Change in left ventricular volumes, particularly end-systolic volume index is a major representative of left ventri cular dilatation, and is a predictor of mortality after acute myocardial infarction of anterior localization. Several large-scale trials have demonstrated beneficial effectiveness of ACE inhibitors on the process of left ventricular remodeling after myo cardial infarction, not only in patients with compromised systolic function. Aim of the study was to evaluate the influence of therapy for ACE inhibitors in the early faze of anterior myocardial infarction, trough dynamics of left ventricular volume in dexes. During six months 30 patients were evaluated with echocardiography in admission, before leaving the hospital, after
three and six months after myocardial infarction. In evaluated group there was increased end-diastolic and end-systolic vo lume index, but without statistically significant value. There were no new cardiac decompensations. We concluded that ACE inhibitors given in the early stage of acute myocardial infarction anterior localization have beneficial effect on the process of left ventricular remodeling and that is recommended to bee given to this patients, after excluded contraindications

Keywords

Left ventricular volume,

ACE inhibitors,

Myocardial infarction

References

1.
Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. New England Journal of Medicine. 319(13):806–11.
2.
Group CCSC. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1. Lancet. 345(8967):686–7.
3.
Group ISIS 4 C. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 345(8958):669–85.
4.
Ambrosioni E, Borghi C, Magnani B. for the Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators. Lancet. 343(8911):1115–22.
5.
Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Circulation. 59(3):421–30.
6.
Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. Journal of the American Society of Echocardiography. 2(5):358–68.
7.
Pfeffer MA, Pfeffer JM. Ventricular enlargement and reduced survival after myocardial infarction. Circulation. 75(1):93–7.
8.
McKay KG, Pfeffer MA, Pasternak RC. Left ventricular remodeling after myocardial infarction: Corollary of infarct expansion. Circulation. 74(4):693–702.
9.
Zar JH. Biostatistical Analysis.
10.
Numeričke i statističke metode u obradi eksperimentalnih podataka.
11.
Investigators TSOLVD. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine. 327(10):685–91.
12.
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II. New England Journal of Medicine. 327(10):678–84.
13.
Sharpe N, Murphy J, Smith H, Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1(8581):2559–60.
14.
Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition. Lancet. 337(8730):872–6.
15.
Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, et al. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine. 333(25):1670–6.
16.
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet. 342(8866):821–8.
17.
Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial (SAVE. New England Journal of Medicine. 327(10):669–77.
18.
Ambrosioni E, Borghi C, Magnani B. for the Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators. New England Journal of Medicine. 332(12):805–10.
19.
Group CCSC. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1. Lancet. 345(8967):686–7.
20.
Group ISIS 4 C. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 345(8958):669–85.
21.
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI-3. Lancet. 343(8910):1115–22.

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by
DOAJ
Google Scholar
ERIHPLUS
MIAR I
Crossref